Cost-Effectiveness Analysis of Omalizumab Compared With Standard of Care For Severe Allergic Asthma Based On Real World Evidence in Japan
Sep 1, 2018, 00:00
10.1016/j.jval.2018.07.791
https://www.valueinhealthjournal.com/article/S1098-3015(18)33148-6/fulltext
Title :
Cost-Effectiveness Analysis of Omalizumab Compared With Standard of Care For Severe Allergic Asthma Based On Real World Evidence in Japan
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)33148-6&doi=10.1016/j.jval.2018.07.791
First page :
Section Title :
Open access? :
No
Section Order :
36